Clinical Trials Logo

Wegener Granulomatosis clinical trials

View clinical trials related to Wegener Granulomatosis.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01446211 Terminated - Clinical trials for Wegeners Granulomatosis

Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis

SPARROW
Start date: November 2011
Phase: Phase 3
Study type: Interventional

The aim of the study is to assess the efficacy (superiority testing) of gusperimus compared to conventional treatment in patients with a relapse of Wegener Granulomatosis with or without ongoing steroids, and/or immunosuppressive therapy. Further, to evaluate the safety and quality of life of gusperimus treatment compared to standard treatment in patients with relapse of Wegener Granulomatosis receiving glucocorticoids.

NCT ID: NCT01408836 Terminated - Clinical trials for Microscopic Polyangiitis

Plasma Exchange for Renal Vasculitis

MEPEX
Start date: March 1995
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to test whether additional therapy with plasma exchange improves the chances of kidney recovery in severe kidney vasculitis.

NCT ID: NCT00747461 Terminated - Sarcoidosis Clinical Trials

Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")

ICEtheBAD
Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the safety, effectiveness, and side effects of the CryoSpray AblationTM System (CryoSpray AblationTM, "CSA" or "cryospray therapy") to treat benign airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB)